Shrikant Vaidya, MD
Urology · Point Pleasant, WVNPI 1316082555
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Axonics, Inc. at 51.9% of the total. Reporting peaked in 2021 at $1,583 and has fallen 93.7% since, to $100 in 2024. That places this record below the midpoint for urology clinicians in WV, where the typical reported total is $2,534.
Across 37 payments — averaging $69.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Astellas Pharma US Inc$602
- Endo Pharmaceuticals Inc.$284
- Pfizer$87
- Boston Scientific$63
- Johnson & Johnson$40
- plus $153 from 6 others
What the payments were for
- Travel & lodging$95537%
- Food & beverage$1,09243%
- Education$50920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 12 | $1,328 |
| Astellas Pharma US Inc | 12 | $602 |
| Endo Pharmaceuticals Inc. | 3 | $284 |
| Pfizer | 1 | $87 |
| Boston Scientific | 1 | $63 |
| Johnson & Johnson | 1 | $40 |
| Myriad Genetic Laboratories, Inc. | 2 | $35 |
| Merck | 1 | $32 |
| Amgen | 1 | $30 |
| Novartis | 1 | $22 |
| Endo USA, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bulkamid$933
- Axonics r-SNM System$933
- XIAFLEX$259
How this compares
$2,556 in reported general payments places this provider in the 50th percentile of 67 urology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $11,631 |
| Solifenacin Succinate | 17 | $2,546 |
| Oxybutynin Chloride ErOxybutynin Chloride | 88 | $1,852 |
| Tamsulosin Hcl | 125 | $1,352 |
| Finasteride | 87 | $1,187 |
| Testosterone Cypionate | 15 | $590 |
| Cephalexin | 88 | $395 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $201 |
| Ciprofloxacin Hcl | 13 | $95 |
| Phenazopyridine Hcl | 11 | $78 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $602 | $11,63116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 67 urology providers in West Virginia.
Other urology in Point Pleasant
- Jaschar Shakuri-RadMorgantown$77K
- Ali HajiranMorgantown$37K
- Lynnetta PayneBeckley$23K
- Stanley ZaslauHuntington$14K
- John BarnardMorgantown$10K
- Mohamad SalkiniMorgantown$8K
- Joshua LohriCharleston$8K
- Nathan HaleCharleston$7K
- Rocco MorabitoHuntington$6K
- Samuel DeemCharleston$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.